NCT00023166View on ClinicalTrials.gov

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas

PHASE1TerminatedINTERVENTIONAL
Timeline

Start Date

May 31, 2001

Study Completion Date

May 31, 2002

Conditions
NeoplasmLymphomasNeoplasm Metastasis
Interventions
DRUG

PEG-paclitaxel

Sponsors
All Listed Sponsors
lead

Enzon Pharmaceuticals, Inc.

INDUSTRY

NCT00023166 - Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas | Biotech Hunter | Biotech Hunter